跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,789 条关于
“H1 receptors”
全部
5,789
临床试验
3,478
药物
658
机构
7
资讯
1,646
9个月前
European Commission Approves Dupixent as First-Line Targeted Therapy for Chronic Spontaneous Urticaria
去年
FDA Accepts Dupixent sBLA for Chronic Spontaneous Urticaria Treatment
去年
FDA Accepts Dupixent sBLA for Chronic Spontaneous Urticaria Treatment
去年
FDA Accepts Dupixent sBLA for Chronic Spontaneous Urticaria Treatment
去年
FDA Accepts Dupixent sBLA for Chronic Spontaneous Urticaria Treatment
去年
Evommune's MRGPRX2 Antagonist EVO756 Shows Promise in Chronic Urticaria Trials
去年
Sequana Medical Anticipates FDA Approval for Alfapump in Q1 2025, Highlights DSR Progress
去年
NMDA Receptor Research Reveals Novel Mechanism for Brain Stabilization and Potential Depression Treatments
2年前
Newron's Evenamide Shows Promise in Treatment-Resistant Schizophrenia
2个月前
Lonza Upgrades 2026 Margin Outlook as H1 Performance Surges Across All Business Platforms
第 1 页,共 165 页
上一页
下一页